~~<i id='D7AFD8C44A'><strike id='D7AFD8C44A'><tt id='D7AFD8C44A'><pre id='D7AFD8C44A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

fashion

author：comprehensive 2025-09-29 21:28:51 - browse：7227

An FDA sign — health policy coverage from STAT — Sarah Silbiger/Getty Images

WASHINGTON — There’s about to be a new acronym in town.

The Food and Drug Administration is in the final stages of cementing sweeping changes to the Office of Regulatory Affairs, which oversees inspections and compliance for all its regulated products, according to three people familiar with the planning.

That overhaul includes a new name: Meet the Office of Inspections and Investigations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： New oral drug delivery patch is modeled after octopus tentacles

hotspot

focus

knowledge

focus

knowledge

LungcancerAdobeCHICAGO—DelfiDiagnostics,acompanyseekingtodevelopliquidbiopsyteststohelpscreenforlung

WSS

Medicare Advantage's lean provider networks lead CMS complaints

Lawsuit highlights wrinkle for disputes over surprise medical bills

ASCO Takeaways: Winners, snoozers, and the art of cancer care

Fight over Supreme Court dialysis ruling puts kidney patients at risk

Illumina board agrees to spin off Grail, as divestment plans proceed

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

hotspot

fashion

hotspot

In Memoriam: Notable people who died in 2023

With Roe v Wade overturned, abortion providers work to adapt

Tori Bowie and the unacceptable rates of Black maternal death

The Karikó problem: Lessons for funding basic research

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

ASCO Daily Recap: CAR

Novavax promises a turnaround & Lilly roils the obesity market

Some top drug companies are starting to take action on climate

Novavax promises a turnaround & Lilly roils the obesity market

Stopping antidepressants leads to symptoms for 1 in 6 patients

hotspot

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Anthony Fauci pushes back on GOP claims during Covid hearing

What we owe ALS patients — and why one company fell short

STAT wants to know your pick for a great summer read or listen

WHO recommends second malaria vaccine

European officials brace for rough respiratory virus season

focus

knowledge

focus

knowledge